A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHRÖDER, N. et al. Cannabidiol and neuroprotection: evidence from preclinical studies. Handbook of Cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment. Tradução . London: Elsevier, 2017. p. 1143 . Disponível em: https://doi.org/10.1016/B978-0-12-800756-3.00095-8. Acesso em: 11 ago. 2024.
APA
Schröder, N., Silva, V. K., Hallak, J. E. C., Zuardi, A. W., & Crippa, J. A. de S. (2017). Cannabidiol and neuroprotection: evidence from preclinical studies. In Handbook of Cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment (p. 1143 ). London: Elsevier. doi:10.1016/B978-0-12-800756-3.00095-8
NLM
Schröder N, Silva VK, Hallak JEC, Zuardi AW, Crippa JA de S. Cannabidiol and neuroprotection: evidence from preclinical studies [Internet]. In: Handbook of Cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment. London: Elsevier; 2017. p. 1143 .[citado 2024 ago. 11 ] Available from: https://doi.org/10.1016/B978-0-12-800756-3.00095-8
Vancouver
Schröder N, Silva VK, Hallak JEC, Zuardi AW, Crippa JA de S. Cannabidiol and neuroprotection: evidence from preclinical studies [Internet]. In: Handbook of Cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment. London: Elsevier; 2017. p. 1143 .[citado 2024 ago. 11 ] Available from: https://doi.org/10.1016/B978-0-12-800756-3.00095-8
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Rafael Guimarães dos et al. Cannabidiol for the treatment of drug use disorders. Handbook of Cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment. Tradução . London: Elsevier, 2017. p. 1143 . Disponível em: https://doi.org/10.1016/B978-0-12-800756-3.00113-7. Acesso em: 11 ago. 2024.
APA
Santos, R. G. dos, Hallak, J. E. C., Zuardi, A. W., & Crippa, J. A. de S. (2017). Cannabidiol for the treatment of drug use disorders. In Handbook of Cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment (p. 1143 ). London: Elsevier. doi:10.1016/B978-0-12-800756-3.00113-7
NLM
Santos RG dos, Hallak JEC, Zuardi AW, Crippa JA de S. Cannabidiol for the treatment of drug use disorders [Internet]. In: Handbook of Cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment. London: Elsevier; 2017. p. 1143 .[citado 2024 ago. 11 ] Available from: https://doi.org/10.1016/B978-0-12-800756-3.00113-7
Vancouver
Santos RG dos, Hallak JEC, Zuardi AW, Crippa JA de S. Cannabidiol for the treatment of drug use disorders [Internet]. In: Handbook of Cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment. London: Elsevier; 2017. p. 1143 .[citado 2024 ago. 11 ] Available from: https://doi.org/10.1016/B978-0-12-800756-3.00113-7
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Rafael Guimarães dos et al. Cannabidiol for the treatment of epilepsy: an overview of possible mechanisms of action and preclinical and human studies. Handbook of Cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment. Tradução . London: Elsevier, 2017. p. 1143 . Disponível em: https://doi.org/10.1016/B978-0-12-800756-3.00094-6. Acesso em: 11 ago. 2024.
APA
Santos, R. G. dos, Hallak, J. E. C., Zuardi, A. W., Crippa, A. C. de S., & Crippa, J. A. de S. (2017). Cannabidiol for the treatment of epilepsy: an overview of possible mechanisms of action and preclinical and human studies. In Handbook of Cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment (p. 1143 ). London: Elsevier. doi:10.1016/B978-0-12-800756-3.00094-6
NLM
Santos RG dos, Hallak JEC, Zuardi AW, Crippa AC de S, Crippa JA de S. Cannabidiol for the treatment of epilepsy: an overview of possible mechanisms of action and preclinical and human studies [Internet]. In: Handbook of Cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment. London: Elsevier; 2017. p. 1143 .[citado 2024 ago. 11 ] Available from: https://doi.org/10.1016/B978-0-12-800756-3.00094-6
Vancouver
Santos RG dos, Hallak JEC, Zuardi AW, Crippa AC de S, Crippa JA de S. Cannabidiol for the treatment of epilepsy: an overview of possible mechanisms of action and preclinical and human studies [Internet]. In: Handbook of Cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment. London: Elsevier; 2017. p. 1143 .[citado 2024 ago. 11 ] Available from: https://doi.org/10.1016/B978-0-12-800756-3.00094-6
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZUARDI, Antonio Waldo et al. Cannabidiol. Cannabis und cannabinoide: pharmakologie, toxikologie und therapeutisches potenzial. Tradução . Bern: Verlag Hans Huber, 2002. . . Acesso em: 11 ago. 2024.
APA
Zuardi, A. W., Guimarães, F. S., Guimarães, V. M. C., & Del Bel, E. A. (2002). Cannabidiol. In Cannabis und cannabinoide: pharmakologie, toxikologie und therapeutisches potenzial. Bern: Verlag Hans Huber.
NLM
Zuardi AW, Guimarães FS, Guimarães VMC, Del Bel EA. Cannabidiol. In: Cannabis und cannabinoide: pharmakologie, toxikologie und therapeutisches potenzial. Bern: Verlag Hans Huber; 2002. [citado 2024 ago. 11 ]
Vancouver
Zuardi AW, Guimarães FS, Guimarães VMC, Del Bel EA. Cannabidiol. In: Cannabis und cannabinoide: pharmakologie, toxikologie und therapeutisches potenzial. Bern: Verlag Hans Huber; 2002. [citado 2024 ago. 11 ]